Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats

International Urology and Nephrology

Volumn 46, Issue 10, 2014, Pages 2045-2051

  Hou, Ningning ^a   Huang, Na ^a   Han, Fang ^a   Zhao, Jiangang ^a   Liu, Xue ^a   Sun, Xiaodong ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Diabetic nephropathy; Microalbuminuria; Nitric oxide; Vascular endothelial growth factor

Indexed keywords

ADENOVIRUS VECTOR; ADIPONECTIN; ALBUMIN; C REACTIVE PROTEIN; CD34 ANTIGEN; MALONALDEHYDE; NITRIC OXIDE; VASCULOTROPIN; BIOLOGICAL MARKER; ETHYLENEDIAMINE DERIVATIVE; GRIESS REAGENT; STREPTOZOCIN; SULFANILAMIDE DERIVATIVE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GLUCOSE BLOOD LEVEL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MALE; MICROALBUMINURIA; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; URINARY EXCRETION; VASODILATATION; WESTERN BLOTTING; ALBUMINURIA; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; ENDOTHELIUM; GLOMERULUS; METABOLISM; RANDOMIZATION; URINALYSIS; URINE; WISTAR RAT;

ADIPONECTIN; ALBUMINURIA; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENDOTHELIUM; ETHYLENEDIAMINES; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; MALE; NITRIC OXIDE; RANDOM ALLOCATION; RATS; RATS, WISTAR; STREPTOZOCIN; SULFANILAMIDES; URINALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907590036     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-014-0807-x     Document Type: Article

References (21)

1. Salvatore SP, Reddi AS, Chandran CB, Chevalier JM, Okechukwu CN, Seshan SV (2014) Collapsing glomerulopathy superimposed on diabetic nephropathy: insights into etiology of an under-recognized, severe pattern of glomerular injury. Nephrol Dial Transplant 29(2):392-399
2. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ et al (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106(14):1777-1782
3. Klausen KP, Parving HH, Scharling H, Jensen JS (2009) Microalbuminuria and obesity: impact on cardiovascular disease and mortality. Clin Endocrinol (Oxf) 71(1):40-45
4. Nakagawa T, Sato W, Kosugi T, Johnson RJ (2013) Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy. J Diabetes Res 2013:184539
5. Sun X, Yu Y, Han L (2013) High FFA levels related to microalbuminuria and uncoupling of VEGF-NO axis in obese rats. Int Urol Nephrol 45(4):1197-1207
6. Tian S, Gan Y, Li J, Wang L, Shen J, Liu T et al (2011) Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate. J Nephrol 24(4):499-506
7. Nakamaki S, Satoh H, Kudoh A, Hayashi Y, Hirai H, Watanabe T (2011) Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Exp Biol Med (Maywood) 236(5):614-620
8. Wang B, Yu Y, Han L (2012) Adiponectin improves endothelial dysfunction caused by elevated FFAs levels, partially through cAMP-dependent pathway. Diabetes Res Clin Pract 97(1):119-124
9. Hou N, Han F, Wang M, Huang N, Zhao J, Liu X et al (2014) Perirenal fat associated with microalbuminuria in obese rats. Int Urol Nephrol 46(4):839-845
10. Sun X, Han F, Yi J, Hou N, Cao Z (2013) The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro. Mol Med Rep 7(5):1636-1640
11. Sun X, Han F, Yi J, Han L, Wang B (2011) Effect of aspirin on the expression of hepatocyte NF-kappaB and serum TNF-alpha in streptozotocin-induced type 2 diabetic rats. J Korean Med Sci 26(6):765-770
12. Wang HJ, Jin YX, Shen W, Neng J, Wu T, Li YJ et al (2007) Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac J Clin Nutr 16(Suppl 1):412-417
13. Kono T, Saito M, Kinoshita Y, Satoh I, Shinbori C, Satoh K (2006) Real-time monitoring of nitric oxide and blood flow during ischemia-reperfusion in the rat testis. Mol Cell Biochem 286(1-2):139-145
14. Spranger J (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361(9353):226228
15. von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B et al (2009) Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes 58(9):2093-2099
16. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51(4):1157-1165
17. Stehouwer CD (2004) Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease. Nephrol Dial Transplant 19(4):778-781
18. Nakagawa T (2007) Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol 292(6):F1665-F1672
19. Feliers D, Chen X, Akis N, Choudhury GG, Madaio M, Kasinath BS (2005) VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int 68(4):1648-1659
20. Nakagawa T, Sato W, Sautin YY, Glushakova O, Croker B, Atkinson MA et al (2006) Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy. J Am Soc Nephrol 17(3):736-745
21. Hattori Y, Nakano Y, Hattori S, Tomizawa A, Inukai K, Kasai K (2008) High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells. FEBS Lett 582(12):1719-1724